Searchable abstracts of presentations at key conferences in endocrinology

ea0028p96 | Clinical practice/governance and case reports | SFEBES2012

Cyclical Cushing’s disease in an obese patient

Seetho Ian , Chee Carolyn , Tan Garry

When investigating patients for possible Cushing’s, repeat testing should be considered despite initial negative results if there is a high index of suspicion. We report a case of a patient whose initial tests for Cushing’s yielded conflicting results; cyclical Cushing’s Disease was diagnosed following persistent testing. A 40 year-old lady (BMI 38.0 kg/m2) was seen in the obesity clinic with a 12-month history of weight gain. She had clinical feature...

ea0077p202 | Metabolism, Obesity and Diabetes | SFEBES2021

Estimation of body fatness in obesity and partial lipodystrophy in relation to eligibility for bariatric surgery: What should be measured?

Efthymiadis Agathoklis , Vasan Senthil K , Tan Garry D , Karpe Fredrik

Introduction: Eligibility for bariatric surgery in the Unighted Kingdom is based on specific body mass index (BMI) thresholds and the presence of obesity-associated complications. Patients with partial lipodystrophy (LD) often have an abundance of metabolic and cardiovascular complications, but their abdominal adiposity does not always substantially increase BMI. The consequence is that patients with LD may be inappropriately excluded from obesity treatments when judged by BMI...

ea0086p212 | Metabolism, Obesity and Diabetes | SFEBES2022

Can improved glycaemic control improve NAFLD independent of weight loss in patients with type 2 diabetes?

Colosimo Santo , Tan Garry , Marchesini Giulio , Tomlinson Jeremy

Aim: The current focus for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) is lifestyle intervention with the aim of significant weight loss. NAFLD is tightly associated with type 2 diabetes (T2D) and obesity. In patients with T2D, glucose lowering agents that promote weight loss have shown a beneficial impact on NAFLD. However, it remains unclear as to whether glucose lowering can improve NALFD in patients with T2D, independent of weight loss.<p class="abstext"...

ea0094oc6.6 | Metabolism, Obesity and Diabetes | SFEBES2023

Low carbohydrate diets in Type 1 diabetes – defining the degree of glycaemic control and nutritional ketosis

Ozoran Hakan , Karpe Fredrik , Dyson Pam , Tan Garry , Matheou Michael

Background: Carbohydrate-restricted diets in type 1 diabetes mellitus (T1DM) are highly controversial. A commonly held concern is that a low carbohydrate diet may more readily result in conversion to diabetic ketoacidosis – one of the most severe complications of poorly managed T1DM. Of note, there is no clear evidence for this phenomenon. We evaluated metabolic profiles in patients with T1DM who had self-selected carbohydrate-restricted diets.<p clas...

ea0055oc9 | National Clinical Cases | SFEEU2018

Appearances can deceive - a rare presentation of paraganglioma

Anguelova Lia , Dhere Archana , Tadman Mike , Tan Garry , Jafar-Mohamadi Bahram

Case: A 36-year-old gentleman presented with two month history of severe headaches, vomiting, polyuria and polydipsia. He reported profound episodic sweating especially on exertion and gradual weight loss. He was hypertensive (220/110 mmHg) at presentation. He had no palpitations, anxiety, dizziness, flushing or pallor. He had no diarrhoea or abdominal pain. His only family history was of Type 2 diabetes mellitus.Investigation: Biochemical investigations...

ea0091p28 | Poster Presentations | SFEEU2023

Mitochondrial DNA Depletion syndrome 1 (MNGIE type) – a rare cause of premature ovarian failure?

Matheou Michael , Tan Garry D , Karpe Fredrik , Brady Stefen , Kent Louisa , Javaid Kassim , Marshall Jonathan , Shears Deborah , Turner Helen E

Case history: A 39 year old lady was being investigated and managed for premature ovarian insufficiency (onset aged 29y) associated with an unusual constellation of symptoms. Following normal childhood and pubertal development, she subsequently developed fatigue, multiple gastrointestinal symptoms and was underweight with evidence of weight loss, and a most recent BMI of 17 kg/m2. She had previously been reviewed due to marked absence of subcutaneous fat in the lowe...

ea0094p53 | Metabolism, Obesity and Diabetes | SFEBES2023

The role of glycated haemoglobin in predicting disease severity in non-alcoholic fatty liver disease

Colosimo Santo , Miller Hamish , Koutoukidis Dimitrios , Marjot Thomas , Tan Garry , Harman David , Aithal Guruprasad , Manousou Pinelopi , Forlano Roberta , Parker Richard , Sheridan David , Newsome Philip , Alazawi William , Cobbold Jeremy , Tomlinson Jeremy

Introduction: The relationship between non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes is well-established. However, the precise impact of glucose control on the severity and progression of NAFLD remains largely unexplored. Currently, none of the non-invasive scoring systems used to assess NAFLD severity incorporate glucose control markers, such as glycated hemoglobin (HbA1c).Methods: Data were collected fr...